Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP406340.RAjZ0jA1UB5lE9cDJURdYdxGkebvkt-Qst5uBo26QCZY0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP406340.RAjZ0jA1UB5lE9cDJURdYdxGkebvkt-Qst5uBo26QCZY0130_assertion type Assertion NP406340.RAjZ0jA1UB5lE9cDJURdYdxGkebvkt-Qst5uBo26QCZY0130_head.
- NP406340.RAjZ0jA1UB5lE9cDJURdYdxGkebvkt-Qst5uBo26QCZY0130_assertion description "[Because GRPR transactivates the epidermal growth factor receptor (EGFR), we investigated induction by GRP of Akt, an EGFR-activated signaling pathway, and examined effects of GRP on viability of non-small cell lung carcinoma (NSCLC) cells exposed to the EGFR tyrosine kinase inhibitor gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406340.RAjZ0jA1UB5lE9cDJURdYdxGkebvkt-Qst5uBo26QCZY0130_provenance.
- NP406340.RAjZ0jA1UB5lE9cDJURdYdxGkebvkt-Qst5uBo26QCZY0130_assertion evidence source_evidence_literature NP406340.RAjZ0jA1UB5lE9cDJURdYdxGkebvkt-Qst5uBo26QCZY0130_provenance.
- NP406340.RAjZ0jA1UB5lE9cDJURdYdxGkebvkt-Qst5uBo26QCZY0130_assertion SIO_000772 17349623 NP406340.RAjZ0jA1UB5lE9cDJURdYdxGkebvkt-Qst5uBo26QCZY0130_provenance.
- NP406340.RAjZ0jA1UB5lE9cDJURdYdxGkebvkt-Qst5uBo26QCZY0130_assertion wasDerivedFrom befree-20140225 NP406340.RAjZ0jA1UB5lE9cDJURdYdxGkebvkt-Qst5uBo26QCZY0130_provenance.
- NP406340.RAjZ0jA1UB5lE9cDJURdYdxGkebvkt-Qst5uBo26QCZY0130_assertion wasGeneratedBy ECO_0000203 NP406340.RAjZ0jA1UB5lE9cDJURdYdxGkebvkt-Qst5uBo26QCZY0130_provenance.